Author

T. Adamus

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Herrmann· 1 shared A. Ledesma· 1 shared C. Lahtz· 1 shared C. Yue· 1 shared E. Yei· 1 shared H. Ji· 1 shared H. Zhou· 1 shared J. Maruyama· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Herrmann

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyCell Death & DiseasePeer-reviewedJan 19, 2023

Impact of AMPK on cervical carcinoma progression and metastasis

P. Konieczny, T. Adamus, M. Sulkowski, M. Majka

This study shows that AMPK activity inhibits cervical cancer metastasis and progression by regulating metabolic processes and invasive phenotype.

DOI 10.1038/s41419-023-05583-9

humanexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivPreprintJun 29, 2020

A Targeted Vaccine against COVID-19: S1-Fc Vaccine Targeting the Antigen-Presenting Cell Compartment Elicits Protection against SARS-CoV-2 Infection

A. Herrmann, J. Maruyama, C. Yue…·H. Ji

This paper develops a S1-Fc vaccine targeting antigen-presenting cells, showing it elicits protective anti-SARS-CoV-2 IgG and T cell responses, with high protection at low doses.

DOI 10.1101/2020.06.29.178616

humanproteomics

𝕏 PostBluesky